Search Results - Shakeel Modak

Refine Results
  1. 1
    Anti-GD2 immunotherapy for neuroblastoma

    Anti-GD2 immunotherapy for neuroblastoma by Sameer Farouk Sait, Shakeel Modak

    Published 2017
    Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Norepinephrine Transporter as a Target for Imaging and Therapy

    Norepinephrine Transporter as a Target for Imaging and Therapy by Neeta Pandit‐Taskar, Shakeel Modak

    Published 2017
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Management of desmoplastic small round cell tumor

    Management of desmoplastic small round cell tumor by Andrea Hayes‐Jordan, Michael P. LaQuaglia, Shakeel Modak

    Published 2016
    Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Sensitivity of Surveillance Studies for Detecting Asymptomatic and Unsuspected Relapse of High-Risk Neuroblastoma

    Sensitivity of Surveillance Studies for Detecting Asymptomatic and Unsuspected Relapse of High-Risk Neuroblastoma by Brian H. Kushner, Kim Kramer, Shakeel Modak, Nai-KongV. Cheung

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Successful Multifold Dose Escalation of Anti-G<sub>D2</sub> Monoclonal Antibody 3F8 in Patients With Neuroblastoma: A Phase I Study

    Successful Multifold Dose Escalation of Anti-G<sub>D2</sub> Monoclonal Antibody 3F8 in Patients With Neuroblastoma: A Phase I Study by Brian H. Kushner, Kim Kramer, Shakeel Modak, Nai‐Kong V. Cheung

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Irinotecan Plus Temozolomide for Relapsed or Refractory Neuroblastoma

    Irinotecan Plus Temozolomide for Relapsed or Refractory Neuroblastoma by Brian H. Kushner, Kim Kramer, Shakeel Modak, Nai‐Kong V. Cheung

    Published 2006
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Ototoxicity from high‐dose use of platinum compounds in patients with neuroblastoma

    Ototoxicity from high‐dose use of platinum compounds in patients with neuroblastoma by Brian H. Kushner, Amy Budnick, Kim Kramer, Shakeel Modak, Nai‐Kong V. Cheung

    Published 2006
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Combination of bevacizumab, irinotecan, and temozolomide for refractory or relapsed neuroblastoma: Results of a phase II study

    Combination of bevacizumab, irinotecan, and temozolomide for refractory or relapsed neuroblastoma: Results of a phase II study by Shakeel Modak, Brian H. Kushner, Ellen M. Basu, Stephen S. Roberts, Nai‐Kong V. Cheung

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Phase I Trial of a Bivalent Gangliosides Vaccine in Combination with β-Glucan for High-Risk Neuroblastoma in Second or Later Remission

    Phase I Trial of a Bivalent Gangliosides Vaccine in Combination with β-Glucan for High-Risk Neuroblastoma in Second or Later Remission by Brian H. Kushner, Irene Y. Cheung, Shakeel Modak, Kim Kramer, Govind Ragupathi, Nai‐Kong V. Cheung

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Humanized 3F8 Anti-G<sub>D2</sub>Monoclonal Antibody Dosing With Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Resistant Neuroblastoma

    Humanized 3F8 Anti-G<sub>D2</sub>Monoclonal Antibody Dosing With Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Resistant Neuroblastoma by Brian H. Kushner, Irene Y. Cheung, Shakeel Modak, Ellen M. Basu, Stephen S. Roberts, Nai‐Kong V. Cheung

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Murine Anti-GD2 Monoclonal Antibody 3F8 Combined With Granulocyte-Macrophage Colony-Stimulating Factor and 13-<i>Cis</i>-Retinoic Acid in High-Risk Patients With Stage 4 Neuroblastoma in First Remission

    Murine Anti-GD2 Monoclonal Antibody 3F8 Combined With Granulocyte-Macrophage Colony-Stimulating Factor and 13-<i>Cis</i>-Retinoic Acid in High-Risk Patients With Stage 4 Neuroblast... by Nai‐Kong V. Cheung, Irene Y. Cheung, Brian H. Kushner, Irina Ostrovnaya, Elizabeth Chamberlain, Kim Kramer, Shakeel Modak

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Local Control With 21-Gy Radiation Therapy for High-Risk Neuroblastoma

    Local Control With 21-Gy Radiation Therapy for High-Risk Neuroblastoma by Dana L. Casey, Brian H. Kushner, Nai‐Kong V. Cheung, Shakeel Modak, Michael P. LaQuaglia, Suzanne L. Wolden

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Prolonged progression-free survival after consolidating second or later remissions of neuroblastoma with Anti-G<sub>D2</sub>immunotherapy and isotretinoin: a prospective Phase II study

    Prolonged progression-free survival after consolidating second or later remissions of neuroblastoma with Anti-G<sub>D2</sub>immunotherapy and isotretinoin: a prospective Phase II s... by Brian H. Kushner, Irina Ostrovnaya, Irene Y. Cheung, Deborah Kuk, Kim Kramer, Shakeel Modak, Karima Yataghene, Nai‐Kong V. Cheung

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Thiotepa-Based High-Dose Chemotherapy With Autologous Stem-Cell Rescue in Patients With Recurrent or Progressive CNS Germ Cell Tumors

    Thiotepa-Based High-Dose Chemotherapy With Autologous Stem-Cell Rescue in Patients With Recurrent or Progressive CNS Germ Cell Tumors by Shakeel Modak, Sharon L. Gardner, Ira J. Dunkel, Casilda Balmaceda, Marc K. Rosenblum, Douglas C. Miller, Steven Halpern, Jonathan L. Finlay

    Published 2004
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    A phase I/Ib trial targeting the Pi3k/Akt pathway using perifosine: <scp>L</scp>ong‐term progression‐free survival of patients with resistant neuroblastoma

    A phase I/Ib trial targeting the Pi3k/Akt pathway using perifosine: <scp>L</scp>ong‐term progression‐free survival of patients with resistant neuroblastoma by Brian H. Kushner, Nai‐Kong V. Cheung, Shakeel Modak, Oren J. Becher, Ellen M. Basu, Stephen S. Roberts, Kim Kramer, Ira J. Dunkel

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Key role for myeloid cells: Phase II results of anti‐G<sub>D2</sub> antibody 3F8 plus granulocyte‐macrophage colony‐stimulating factor for chemoresistant osteomedullary neuroblastoma

    Key role for myeloid cells: Phase II results of anti‐G<sub>D2</sub> antibody 3F8 plus granulocyte‐macrophage colony‐stimulating factor for chemoresistant osteomedullary neuroblasto... by Nai‐Kong V. Cheung, Irene Y. Cheung, Kim Kramer, Shakeel Modak, Deborah Kuk, Neeta Pandit‐Taskar, Elizabeth Chamberlain, Irina Ostrovnaya, Brian H. Kushner

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Survival Impact of Anti-GD2 Antibody Response in a Phase II Ganglioside Vaccine Trial Among Patients With High-Risk Neuroblastoma With Prior Disease Progression

    Survival Impact of Anti-GD2 Antibody Response in a Phase II Ganglioside Vaccine Trial Among Patients With High-Risk Neuroblastoma With Prior Disease Progression by Irene Y. Cheung, Nai‐Kong V. Cheung, Shakeel Modak, Audrey Mauguen, Yi Feng, Ellen M. Basu, Stephen S. Roberts, Govind Ragupathi, Brian H. Kushner

    Published 2020
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoin

    Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoin by Brian H. Kushner, Irina Ostrovnaya, Irene Y. Cheung, Deborah Kuk, Shakeel Modak, Kim Kramer, Stephen S. Roberts, Ellen M. Basu, Karima Yataghene, Nai‐Kong V. Cheung

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Treatment and outcome of adult‐onset neuroblastoma

    Treatment and outcome of adult‐onset neuroblastoma by Maya Suzuki, Brian H. Kushner, Kim Kramer, Ellen M. Basu, Stephen S. Roberts, William J. Hammond, Michael P. LaQuaglia, Suzanne L. Wolden, Nai‐Kong V. Cheung, Shakeel Modak

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment

    Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment by Nidale Tarek, Jean-Benoît Le Luduec, Meighan M. Gallagher, Junting Zheng, Jeffrey M. Venstrom, Elizabeth Chamberlain, Shakeel Modak, Glenn Heller, Bo Dupont, Nai‐Kong V. Cheung, Katharine C. Hsu

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: